Rapid Dose Therapeutics Corp. (RDTCF)
OTCMKTS · Delayed Price · Currency is USD
0.0760
-0.0140 (-15.56%)
At close: Jan 29, 2026

Rapid Dose Therapeutics Statistics

Total Valuation

RDTCF has a market cap or net worth of 13.39 million. The enterprise value is 17.54 million.

Market Cap13.39M
Enterprise Value 17.54M

Important Dates

The last earnings date was Thursday, January 29, 2026.

Earnings Date Jan 29, 2026
Ex-Dividend Date n/a

Share Statistics

Current Share Class 135.18M
Shares Outstanding n/a
Shares Change (YoY) +7.98%
Shares Change (QoQ) +59.51%
Owned by Insiders (%) 15.13%
Owned by Institutions (%) n/a
Float 114.72M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 6.72
PB Ratio -2.81
P/TBV Ratio n/a
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -5.60
EV / Sales 8.60
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -28.11

Financial Position

The company has a current ratio of 0.08

Current Ratio 0.08
Quick Ratio 0.04
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF -6.62
Interest Coverage -2.38

Financial Efficiency

Return on Equity (ROE) n/a
Return on Assets (ROA) -70.49%
Return on Invested Capital (ROIC) n/a
Return on Capital Employed (ROCE) 69.24%
Weighted Average Cost of Capital (WACC) 3.62%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 1.02
Inventory Turnover 5.88

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -57.78% in the last 52 weeks. The beta is -0.90, so RDTCF's price volatility has been lower than the market average.

Beta (5Y) -0.90
52-Week Price Change -57.78%
50-Day Moving Average 0.11
200-Day Moving Average 0.29
Relative Strength Index (RSI) 44.49
Average Volume (20 Days) 53,354

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, RDTCF had revenue of 1.99 million and -3.13 million in losses. Loss per share was -0.02.

Revenue1.99M
Gross Profit 1.00M
Operating Income -2.20M
Pretax Income -3.13M
Net Income -3.13M
EBITDA -1.89M
EBIT -2.20M
Loss Per Share -0.02
Full Income Statement

Balance Sheet

The company has 78,138 in cash and 4.13 million in debt, with a net cash position of -4.05 million.

Cash & Cash Equivalents 78,138
Total Debt 4.13M
Net Cash -4.05M
Net Cash Per Share n/a
Equity (Book Value) -4.76M
Book Value Per Share -0.04
Working Capital -5.42M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -619,019 and capital expenditures -4,752, giving a free cash flow of -623,771.

Operating Cash Flow -619,019
Capital Expenditures -4,752
Free Cash Flow -623,771
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 50.44%, with operating and profit margins of -110.68% and -157.17%.

Gross Margin 50.44%
Operating Margin -110.68%
Pretax Margin -157.17%
Profit Margin -157.17%
EBITDA Margin -95.17%
EBIT Margin -110.68%
FCF Margin n/a

Dividends & Yields

RDTCF does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -7.98%
Shareholder Yield -7.98%
Earnings Yield -23.37%
FCF Yield -4.66%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

RDTCF has an Altman Z-Score of -20.37 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -20.37
Piotroski F-Score 2